EAN
TGTX icon

Excelsior Advisor Network’s TG Therapeutics TGTX Stock Holding History

Excelsior Advisor Network’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
+30,385
New +$1.24M 0.22% 99

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Excelsior Advisor Network's TGTX Position: Q2 2026 in Review

Excelsior Advisor Network opened a new position in TG Therapeutics (TGTX) in Q2 2026: 30,385 shares worth $1.67M. The stake represents 0.22% of the portfolio and ranks #99 among its holdings.

427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Excelsior Advisor Network held 30,385 shares of TG Therapeutics worth $1.67M as of Q2 2026.
  • TG Therapeutics was a new Excelsior Advisor Network position in Q2 2026.
  • TG Therapeutics made up 0.22% of Excelsior Advisor Network's portfolio in Q2 2026, its #99 holding.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Excelsior Advisor Network's 13F filing for Q2 2026, filed 14 Aug 2026.